Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ritesh InternationalBOM:519097 +2.83%73 EBITDA Margin % is 5.62% as of Jun. 2026, which is 69% above its 10-year median of 3.33. GuruFocus rates BOM:519097 with a GF Score™ of 73/100 and a GF Value™ of ₹66.60 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 1,577 Chemicals companies, Ritesh International ranks worse than 72.99% on this metric.
Ritesh International (BOM:519097) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Ritesh International EBITDA Margin % Related Terms
Ritesh International EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Ritesh International's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Ritesh International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ritesh International EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Ritesh International's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Ritesh International's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ritesh International (BOM:519097) has a EBITDA Margin % of 5.62% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ritesh International and its competitors. This is 69% above median its historical median of 3.33. Over the past decade, Ritesh International's EBITDA Margin % has ranged from 1.57 to 4.92. According to the industry distribution chart, Ritesh International ranks #1151 out of 1577 companies in the Chemicals industry, placing it in the top 73%.
Is Ritesh International's EBITDA Margin % too high?
Ritesh International's current EBITDA Margin % of 5.62% is 69% above median its 10-year median of 3.33. Over the past 10 years, this metric has ranged from a low of 1.57 to a high of 4.92. The Chemicals industry median EBITDA Margin % is 9.64. Ritesh International's value of 5.62% is 41.7% below this industry median. Based on the distribution chart, Ritesh International ranks #1151 out of 1577 companies in the Chemicals industry, which is below the industry midpoint. Overall, Ritesh International has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ritesh International's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Ritesh International ranks #1151 out of 1577 companies for EBITDA Margin %. This places Ritesh International in the lower half of its industry. The industry median EBITDA Margin % is 9.64. Ritesh International's value of 5.62% is 41.7% below this benchmark. Historically, Ritesh International's own EBITDA Margin % has ranged from 1.57 to 4.92 over the past decade. While the company's 10-year median is 3.33 vs. the industry median of 9.64, Ritesh International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ritesh International's current EBITDA Margin % of 5.62% is 41.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Ritesh International and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ritesh International's current EBITDA Margin % is 5.62%, which is 69% above median its own 10-year median of 3.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ritesh International stock overvalued right now?
Based on GuruFocus' analysis, Ritesh International (BOM:519097) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹66.60, compared to a current price of ₹83.07 — trading 24.7% above its estimated fair value. The current EBITDA Margin % is 5.62%, which is 69% above median its 10-year median of 3.33 and 41.7% below the Chemicals industry median of 9.64. Ritesh International's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Ritesh International (BOM:519097), the current EBITDA Margin % is 5.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ritesh International (BOM:519097) Overvalued in 2026?
Based on GuruFocus' analysis, Ritesh International stock appears to be overvalued.
The current stock price of ₹83.07 is trading 24.7% above its estimated GF Value™ of ₹66.60.
GuruFocus considers Ritesh International to be Modestly Overvalued.
Key valuation signals for BOM:519097:
EBITDA Margin %: 5.62% (69% above median its 10-year median of 3.33)
GF Value™: ₹66.60 vs. price of ₹83.07 (24.7% above fair value)
Industry Position: 41.7% below the Chemicals median (#1151 of 1577)
No single metric tells the full story. See the BOM:519097 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ritesh International Ltd is engaged in the business of manufacturing and selling of Stearic Acid, Fatty Acids, glycerin and Readymade Garments. The company generates revenue mainly from sale of Stearic Acids and Other Non-edible Oils.
73GF Score
Get the complete analysis for BOM:519097
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:519097 has been successfully added to your 
